A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance Leopold
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- Oxford University Hospitals Nhs Trust
Oxford, United Kingdom
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- the Angeles Clinic and Research Institute
Los Angeles, California, United States
- Usc Norris Cancer Center
Los Angeles, California, United States
- Ucsf - University of California San Francisco
San Francisco, California, United States
- University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
- the University of Kansas Clinical Research Center
Fairway, Kansas, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Lahey Hospital & Medical Center
Burlington, Massachusetts, United States
- Columbia University, Herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Nyu Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest Medical Center Boulevard
Winston-Salem, North Carolina, United States
- Sanford Research
Fargo, North Dakota, United States
- University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
- Sanford Research
North Sioux City, South Dakota, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Texas Oncology Research
Austin, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Utah Cancer Specialists
Salt Lake City, Utah, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Nov 2014
- Primary completion
- 16 Jun 2020
- Completion
- 16 Jun 2020
- Last update posted
- 14 Aug 2025
- Registered enrollment
- 307
- Registry id
- NCT02327078
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.